Manufacturer record
Life Vision Healthcare: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Life Vision Healthcare (Himachal Pradesh) were declared Not of Standard Quality between November 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Life Vision Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ferrous Ascorbate & Folic Acid Tablets IP | LTA-45315AMfg 2024-10 · Exp 2026-09 | The sample does not conform to I.P. w.r.to the tests for AssayAssay | SDTL,GuwahatiState lab | Jul 2026 |
| Thyroxine Sodium Tablets IP 50 mcg (Thyroute 50 Tablets) | LTA-4081Mfg 2019-11 · Exp 2021-10 | Uniformity of contentUniformity of weight/content | RDTL ChandigarhCDSCO lab | Jun 2020 |
| Tymolytic AP (Aceclofenac, Paracetamol & Trypsin Chymotrypsin Capsules) | LVC?6286Mfg 2018-12 · Exp 2020-11 | Assay of Trypsin ChymotrypsinAssay | CDL KolkataCDSCO lab | Feb 2020 |
| Telmisartan Tablets I.P. 40mg. (Telziver-40) | LVT-28800Mfg 2018-04 · Exp 2020-03 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.